Jadwiga Hołojda

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

Elżbieta Iskierka‐Jazdzewska, Marek Hus, Krzysztof Giannopoulos et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 39 citations

Medicine, Oncology, Pharmacology +14

Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma

Aleksander Salomon‐Perzyński, Adam Walter‐Croneck, Lidia Usnarska‐Zubkiewicz et al. · Advances in Medical Sciences · 2019 · 25 citations

Medicine, Oncology, Pharmacotherapy +13

Ibrutinib discontinuation in patients with relapsed or refractorychronic lymphocytic leukemia treated in acompassionate use program:A report from the Polish Adult Leukemia Study Group (PALG)

Elżbieta Iskierka‐Jazdzewska, Bartosz Puła, Agnieszka Szeremet et al. · Advances in Clinical and Experimental Medicine · 2019 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype – retrospective analysis of Polish Adult Leukemia Group (PALG)

Agnieszka Wierzbowska, Ewa Wawrzyniak, Monika Siemieniuk‐Ryś et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 11 citations

Life Sciences, Hematology, Oncology +15

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group*

Tomasz Wróbel, Przemysław Biecek, Justyna Rybka et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 10 citations · Full text

Medicine, Geriatric Medicine, Oncology +10